CoChat

Epidemiological challenges in studying the fetal origins of adult chronic disease

Open access
Gillman, M. W · 2002 · International Journal of Epidemiology
Cited by 122

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The relatively new research field of the fetal origins of adult disease has matured greatly in the past decade. Recent systematic overviews provide strong evidence that robust inverse epidemiological associations exist between birthweight and later blood pressure/hypertension1 and glucose intolerance/type 2 diabetes.2 Consistent associations are also evident for the inverse associations of birthweight with coronary heart disease incidence and mortality.3,4 Studies with high follow-up rates and adjustment for social and economic variables have to a large extent mitigated earlier criticisms that observed associations were highly subject to confounding and selection bias.5 Many questions remain, however, about the contributing roles of postnatal growth and development, underlying biological mechanisms, and the importance of the epidemiological findings to public health. This review outlines current challenges—stated in the form of propositions—that epidemiologists in this field currently face. The lifecourse approach to chronic disease posits that fetal life is one important period of development, but not the only one, in determining susceptibility to adult chronic disease.6 Many studies have now shown that associations of birth size with later cardiovascular outcomes are modified by body mass index in adulthood or, indeed, in childhood.7,8 The highest risk is typically among adults who were born small and become overweight during childhood or adulthood. Examples of outcomes that fit this profile include insulin resistance in Indian 8-year-old boys and girls,9 blood pressure levels among 50-year-old Swedish men,10 and incidence of coronary heart disease among middle to older age Welsh men.4 In another example, body mass index at age 11 appeared to modify the association of ponderal index at birth with adult coronary disease risk in Finnish males.7 From this observed phenomenon some have inferred that that postnatal ‘catch up growth’ modifies intrauterine influences. There are two problems with this inference. First, most studies to date include only two weight points—one at birth and one later in life. Without a third, intermediate, point, it is difficult to distinguish whether the findings represent an interaction between fetal and postnatal exposures or merely some facets of postnatal growth itself.11 Some recent studies, however, have had multiple postnatal measures of height and weight. Overall they have suggested that both intrauterine and postnatal growth are important, but it is not clear exactly which periods are important or even whether increased or decreased postnatal growth is harmful. For example, in a Finnish cohort, adult hypertension was associated with both lower birthweight and accelerated growth in the first 7 years of life.12 In contrast, in a small group of Chinese adults, both lower ponderal index at birth and a decrease in ponderal index from 6 to 18 months of life were related to increased systolic blood pressure level at age 30 years.13 Moreover, in two recently reported studies from the UK, catch up growth in the first 6 months of life was not clearly related to young adult blood pressure at all, although birthweight was.14,15 In another study, growth patterns exemplified by lower birthweight followed by reduced growth until age 1 seemed to confer the highest risk for ischaemic heart disease later in life, but the analysis was confined to men.16 These disparate results call for additional serial growth data to determine which periods of growth contribute most to the observed interactions between fetal and postnatal size in determining health outcomes. A second issue is that catch up growth traditionally refers to the first 6–12 months after birth, not later growth. The standard interpretation is that catch up growth represents realignment of one's genetic growth potential after intrauterine growth restriction. One advantage of this interpretation is that it allows for fetal growth restriction at any birthweight—even large fetuses can be growth restricted relative to their genetic potential—thus obviating the need for arbitrary definitions such as ‘small for gestational age’. This distinction is important in the fetal origins of adult disease, since observed associations of birthweight with later outcomes generally span the entire birthweight spectrum, not just at the ‘low birthweight’ end. The major problems, however, are in the measurement of catch up growth. Some investigators resort to a post hoc, empirical definition, using the observed infant growth patterns relative to birthweight.17 A second possibility is that mid-parental height gives a good estimate of the child's growth potential, but usually for height, not relative weight, and the estimation is better after 2 years of age than in infancy. Third, while needing confirmation, recent data raise the possibility that levels of maternal insulin-like growth factor I during pregnancy may reflect fetal growth restriction.18 A final

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/31.2.294

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 122

Metadata

Authors
Gillman, M. W.
Venue
International Journal of Epidemiology
Published
2002-04-01
Volume
31
Issue
2
Pages
294-299
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2138647512
Cited by
122
References
5
FWCI
9.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.